Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
Gainers
Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday.
AgeX Therapeutics Q4 Sales $27.00K Down From $505.00K YoY
AgeX Therapeutics (AMEX:AGE) reported $27.00 thousand in sales this quarter. This is a 94.65 percent decrease over sales of $505.00 thousand the same period last year.
58 Biggest Movers From Yesterday
Gainers
Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs
after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe is no long active.
61 Biggest Movers From Yesterday
Gainers
Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa Immunogene combination therapy.
35 Stocks Moving In Monday’s Mid-Day Session
Gainers
Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-110 for rhabdomyosarcoma, a form of pediatric cancer.
AgeX Therapeutics’ Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed With IMS001
AgeX Therapeutics, Inc. (("AgeX", NYSE:AGE), a biotechnology company focused on developing therapeutics for human aging and regeneration, announced today that ImStem Biotechnology, Inc. ("ImStem"), a
AgeX Therapeutics Q3 EPS $(0.05) Up From $(0.07) YoY
AgeX Therapeutics (AMEX:AGE) reported quarterly losses of $(0.05) per share. This is a 28.57 percent increase over losses of $(0.07) per share from the same period last year.
AgeX Therapeutics Q2 EPS $(0.07), Same YoY, Sales $37.00K Down From $414.00K YoY
AgeX Therapeutics (AMEX:AGE) reported quarterly losses of $(0.07) per share. This is unchanged from the same period last year. The company reported $37.00 thousand in sales this quarter. This is a 91.06 percent decrease